An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001315:Australia; D001663:Bilirubin / Q000097:blood; D001803:Blood Transfusion; D002908:Chronic Disease; D003428:Cross Infection / Q000453:epidemiology*; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000628:therapy; D006506:Hepatitis A / Q000097:blood / Q000150:complications / Q000453:epidemiology* / Q000276:immunology* / Q000517:prevention & control; D006748:Hospital Departments; D006801:Humans; D006869:Hydronephrosis / Q000150:complications / Q000628:therapy; D007519:Isoantigens / Q000032:analysis*; D007565:Jaundice / Q000150:complications; D008297:Male; D008875:Middle Aged; D010414:Pennsylvania; D010564:Personnel, Hospital; D011704:Pyelonephritis / Q000150:complications / Q000628:therapy; D006435:Renal Dialysis; D013997:Time Factors; D005719:gamma-Globulins / Q000627:therapeutic use
D007519:Isoantigens; D005719:gamma-Globulins; D000410:Alanine Transaminase; D001663:Bilirubin